Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Techne Corp announces agreement to acquire Novus Biologicals


Wednesday, 2 Jul 2014 04:15pm EDT 

Techne Corp:Acquires Novus Biologicals for $60 mln in cash.Transaction was financed with cash on hand.Fredrikson & Byron, P.A. is serving as Techne's legal counsel.Choate Hall & Stewart LLP is serving as Novus Biologicals' legal counsel.Transaction closed on July 2, 2014. 

Company Quote

93.32
-0.54 -0.58%
31 Jul 2014